| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/25/2002 | EP1242617A2 Method of classifying a thyroid carcinoma using differential gene expression |
| 09/25/2002 | EP1242611A2 Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein |
| 09/25/2002 | EP1242609A2 Novel colloid synthetic vectors for gene therapy |
| 09/25/2002 | EP1242608A2 Method of achieving persistent transgene expression |
| 09/25/2002 | EP1242607A1 Transgenic insect |
| 09/25/2002 | EP1242605A2 Artificial promoters for protein expression in plants |
| 09/25/2002 | EP1242604A2 Chemical inducible promoter used to obtain transgenic plants with a silent marker and organisms and cells and methods of using same for screening for mutations |
| 09/25/2002 | EP1242603A2 Vectors and method for producing recombinant proteins in fungi |
| 09/25/2002 | EP1242602A1 PROTEIN EXPRESSION SYSTEMS FOR NON-PATHOGENIC i KINETOPLASTIDAE /i |
| 09/25/2002 | EP1242601A1 Trichoderma reesei xylanase |
| 09/25/2002 | EP1242600A1 Cytokine zcyto18 |
| 09/25/2002 | EP1242599A2 Method for obtaining human cdc25 phosphatases and method for identifying human cdc25 phosphatase modulators |
| 09/25/2002 | EP1242597A1 Mutated bmp1b receptor as regulator of ovulation rate |
| 09/25/2002 | EP1242596A1 Methods and materials relating to novel von willebrand/thrombospondin-like polypeptides and polynucleotides |
| 09/25/2002 | EP1242595A1 Promoter and intron from maize actin depolymerizing factor |
| 09/25/2002 | EP1242594A1 Method for isolation of rna from formalin-fixed paraffin-embedded tissue specimens |
| 09/25/2002 | EP1242593A2 A functional gene array in yeast |
| 09/25/2002 | EP1242592A2 A molecular switch for regulating mammalian gene expression |
| 09/25/2002 | EP1242591A1 Production of transgenic animals using nuclear transfer and oocytes recovered by lopu |
| 09/25/2002 | EP1242590A2 Human lyases and associated proteins |
| 09/25/2002 | EP1242589A2 Methods for producing enantiomerically pure alpha-substituted carboxylic acids |
| 09/25/2002 | EP1242588A2 Human proteins with homology to carboxypeptidases and polynucleotides encoding the same |
| 09/25/2002 | EP1242587A1 A NOVEL ISOFORM OF HUMAN cAMP-DEPENDENT PROTEIN KINASE, C ALPHA-s, LOCALIZES TO SPERM MIDPIECE AND THE USE THEREOF |
| 09/25/2002 | EP1242586A1 Rna polymerases from bacteriophage phi 6-phi 14 and use thereof |
| 09/25/2002 | EP1242585A1 IDENTIFICATION OF NOVEL SPLICE VARIANTS OF THE HUMAN CATALYTIC SUBUNIT C BETA OF cAMP-DEPENDENT PROTEIN KINASE AND THE USE THEREOF |
| 09/25/2002 | EP1242584A2 Human kinases |
| 09/25/2002 | EP1242583A2 Human oxidoreductase proteins |
| 09/25/2002 | EP1242580A1 Methods and materials relating to semaphorin-like polypeptides and polynucleotides |
| 09/25/2002 | EP1242577A1 Process for ex vivo formation of mammalian bone and uses thereof |
| 09/25/2002 | EP1242510A1 Particle structures with receptors for analyte detection |
| 09/25/2002 | EP1242459A1 Methods and compositions for determining the purity of chemically synthesized nucleic acids |
| 09/25/2002 | EP1242458A2 Brain specific binding members |
| 09/25/2002 | EP1242457A1 Intrabodies with defined framework that is stable in a reducing environment and applications thereof |
| 09/25/2002 | EP1242456A2 Scfv antibodies against disease associated molecules |
| 09/25/2002 | EP1242449A1 Modified adenovirus fibre and uses |
| 09/25/2002 | EP1242448A2 Endogenous and non-endogenous versions of human g protein-coupled receptors |
| 09/25/2002 | EP1242442A1 Process for the scaleable purification of plasmid dna |
| 09/25/2002 | EP1242441A2 Polynucleotide vaccines expressing codon optimized hiv-1 nef and modified hiv-1 nef |
| 09/25/2002 | EP1242187A1 Contacting device |
| 09/25/2002 | EP1242175A1 Heat-relaxable substrates and arrays |
| 09/25/2002 | EP1242129A2 Biological joint construct |
| 09/25/2002 | EP1242124A1 Polynucleotide vaccines expressing codon optimized hiv-1 pol and modified hiv-1 pol |
| 09/25/2002 | EP1242122A2 Delivery of proteins across polar epithelial cell layers |
| 09/25/2002 | EP1242117A1 Method for treatment of canine distemper |
| 09/25/2002 | EP1242111A1 An animal model for studying hormone signalling and method of modulating the signalling |
| 09/25/2002 | EP1242108A1 Optimized minigenes and peptides encoded thereby |
| 09/25/2002 | EP1242060A1 Treatment of metastatic disease |
| 09/25/2002 | EP1242050A2 Survivin promotion of angiogenesis |
| 09/25/2002 | EP1241936A1 A method to produce cloned embryos and adults from cultured cells |
| 09/25/2002 | EP1241935A2 Methods for producing transgenic animals |
| 09/25/2002 | EP1241934A1 Melanocortin-4 receptor deficient cells, non-human transgenic animals and methods of selecting compounds which regulate body weight |
| 09/25/2002 | EP1241933A1 Melanocortin-3 receptor deficient cells, non-human transgenic animals and methods of selecting compounds which regulate body weight |
| 09/25/2002 | EP1241932A1 Animal models for cardiac disease |
| 09/25/2002 | EP1241931A1 Cloning pigs using donor cells or nuclei from differentiated cells and production of pluripotent porcine. |
| 09/25/2002 | EP1189610A4 Method and markers for prognosticating efficacy of anticancer agents |
| 09/25/2002 | EP1179176A4 Enriched antigen-specific t-cells, and related therapeutic and prophylactic compositions and methods |
| 09/25/2002 | EP1165769B1 Method for fractionating double-stranded nucleic acids in solutions in order to obtain single-stranded nucleic acids |
| 09/25/2002 | EP1115852A4 Expression vectors containing hot spot for increased recombinant protein expression in transfected cells |
| 09/25/2002 | EP1082459A4 A novel method of diagnosing, monitoring, and staging lung cancer |
| 09/25/2002 | EP1060184A4 Best's macular dystrophy gene |
| 09/25/2002 | EP1049800A4 Asthma related genes |
| 09/25/2002 | EP0986296A4 Fatty acid elongases |
| 09/25/2002 | EP0980263B1 Combined product associating a nucleic acid with a substance breaking up the extracellular matrix for gene therapy |
| 09/25/2002 | EP0975765A4 Plant fatty acid epoxygenase genes and uses therefor |
| 09/25/2002 | EP0972020B1 Insulin-like growth factor agonist molecules |
| 09/25/2002 | EP0918540B1 Intradermal bovine polynucleotide vaccine |
| 09/25/2002 | EP0912470B9 Method and device for purifying and enriching molecules |
| 09/25/2002 | EP0863998A4 Double-stranded conformational polymorphism analysis |
| 09/25/2002 | EP0845981B1 Compositions comprising cationic amphiphiles and co-lipids for intracellular delivery of therapeutic molecules |
| 09/25/2002 | EP0804591B1 Serum paraoxonase |
| 09/25/2002 | EP0753070B1 Novel nucleic acid/polymer complexes, method for preparing same and use thereof for cell transfection |
| 09/25/2002 | EP0696320B1 Human n-methyl-d-aspartate receptor subunits, nucleic acids encoding same and uses therefor |
| 09/25/2002 | EP0658207B1 Method for the genetic containment of plants |
| 09/25/2002 | EP0652966B1 Method of increasing expression of viral proteins |
| 09/25/2002 | EP0643774B1 Expression of genes in transgenic plants |
| 09/25/2002 | CN1371428A Tryptophan synthease as site of herbicide action |
| 09/25/2002 | CN1371425A Plant gene expression controlled by constitutive plant V-ATPASE promoters |
| 09/25/2002 | CN1371424A Activatable recombinant neurotoxins |
| 09/25/2002 | CN1371423A Gene coding cyclic lipopeptide acrylase and expression of the same |
| 09/25/2002 | CN1371422A Method for production of L-amino acids from their racemic N-acetyl-D,L-derivatives by enzymatic recombinant enzymes |
| 09/25/2002 | CN1371421A Tankyrase 2 materials and methods |
| 09/25/2002 | CN1371420A Orynebacterium glutamicum genes encoding phosphoenolpyruvate sugar phosphotransferase system proteins |
| 09/25/2002 | CN1371419A DNA encoding sucrose PTS enzyme II |
| 09/25/2002 | CN1371418A Genes from corynebacterium glutamicum for the biosynthesis of folic acid and their use for the microbia production of folic acid |
| 09/25/2002 | CN1371416A Human CTLA-4 antibodies and their uses |
| 09/25/2002 | CN1371415A Fabrication of beta-pleated sheet proteins with specific binding properties |
| 09/25/2002 | CN1371390A Human G-protein coupled receptor |
| 09/25/2002 | CN1371389A 疫苗 Vaccine |
| 09/25/2002 | CN1371378A 28-epirapalogs |
| 09/25/2002 | CN1371303A Method and device for performing operations at charged microlocations |
| 09/25/2002 | CN1371302A Method and device for applying plurality of microdroplets onto substrate |
| 09/25/2002 | CN1371289A Gene therapy using TGF-beta |
| 09/25/2002 | CN1371282A Medicaments that contain xenogenic oligo-or/and polyribonucleotides |
| 09/25/2002 | CN1371243A Corticotropin releasing factor receptor 2 deficient mice and uses thereof |
| 09/25/2002 | CN1370843A Functions of Tob gene in central nervous system of mammol and its application |
| 09/25/2002 | CN1370838A Amidated recombinant polypeptide and its prepn |
| 09/25/2002 | CN1370835A Quantum life gene converting instrument |
| 09/25/2002 | CN1370834A Hog microsatellite DNA mark suitable for use in classifying hog breeds |
| 09/25/2002 | CN1370833A Pit viper venom batroxobin gene cDNA sequence of Dalian Snake Island in Liaoning Prov. of China and its cloning |
| 09/24/2002 | US6455762 Generating transgenic plant; obtain tissue, transorm with vector containing preferential enzymatic polypeptide, regenerate plants, monitor cellulose concentration and adjustment to disease resistance |